Pharma Archives - Page 35 of 80 - Life Sciences Times

Vertex Teams Up with Jayson Tatum to Highlight JOURNAVX, a Non-Opioid Pain Medicine

September 23, 2025

Meet the Man Behind FDA-Approved Bladder Cancer Breakthrough: Dr. Purnanand Sarma and the Journey of INLEXZO™

September 22, 2025

Blue Cross Blue Shield of Massachusetts Appoints Sophie Clarke as Chief Strategy Officer

September 19, 2025

THIS WEEK'S STORIES

Eutecma Names Kevin Grogan CEO to Drive Global Expansion

September 23, 2025

VideaHealth Named to TIME’s World’s Top HealthTech Companies 2025 List

September 18, 2025

Boston Jury Awards $83 Million in Asbestos Verdict Against American Art Clay Company

September 19, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Pharma

FDA Grants Priority Review to ENHERTU and Pertuzumab Combination for First-Line Treatment of HER2-Positive Metastatic Breast Cancer

Actio Biosciences Doses First Participant in Phase 1 Trial of ABS-1230 for KCNT1-Related Epilepsy

FDA Issues Complete Response Letter for Scholar Rock’s Apitegromab, Citing Catalent Facility Observations

Vertex Teams Up with Jayson Tatum to Highlight JOURNAVX, a Non-Opioid Pain Medicine

KalVista Wins EU, Swiss Approvals for EKTERLY, First Oral On-Demand Therapy for Hereditary Angioedema

Most Read

Future Family Names Alden Romney CEO, Founder Claire Tomkins Transitions to Executive Chair

Groups Names Cooper Zelnick as CEO to Lead Next Phase of Growth in Value-Based Addiction Care

MEDiC Life Sciences Acquires Clinical-Stage Oncology Program, Leveraging Biomarker Platform for Precision Medicine

AVS Expands with New Waltham Headquarters as It Prepares for U.S. Launch of PULSE IVL System

EDITOR PICKS

Vertex Teams Up with Jayson Tatum to Highlight JOURNAVX, a Non-Opioid Pain Medicine

Meet the Man Behind FDA-Approved Bladder Cancer Breakthrough: Dr. Purnanand Sarma and the Journey of INLEXZO™

Blue Cross Blue Shield of Massachusetts Appoints Sophie Clarke as Chief Strategy Officer

THIS WEEK'S STORIES

Eutecma Names Kevin Grogan CEO to Drive Global Expansion

VideaHealth Named to TIME’s World’s Top HealthTech Companies 2025 List

Boston Jury Awards $83 Million in Asbestos Verdict Against American Art Clay Company

POPULAR CATEGORY

ABOUT US

FOLLOW US